{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:14:39Z","timestamp":1780672479640,"version":"3.54.1"},"reference-count":0,"publisher":"Aging and Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["aging dis"],"abstract":"<jats:p>Antibody-based immunotherapy represents one of the most promising disease-modifying strategies for Alzheimer\u2019s disease (AD). Recent anti-amyloid-\u03b2 (A\u03b2) antibodies have achieved robust plaque clearance and modest cognitive benefits in early AD, establishing clinical proof of concept. However, limited efficacy and safety concerns, particularly amyloid-related imaging abnormalities (ARIA), continue to restrict their therapeutic potential. This review outlines the current clinical status of antibody therapies targeting A\u03b2, tau, and neuroinflammatory pathways, and summarizes key antibody optimization strategies, including aggregation-state-selective targeting, Fc engineering, brain shuttle technologies, nanobody platforms, and nanotechnology-enabled delivery. We further discuss emerging concepts from tumor immunotherapy, such as antibody-guided protein degradation and conditionally active biologics, as potential avenues for next-generation AD treatment.<\/jats:p>","DOI":"10.14336\/ad.2026.0292","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:52:48Z","timestamp":1780671168000},"source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Antibody-Based Therapies for Alzheimer\u2019s Disease: From Clinical Limitations to Molecular Engineering Innovations"],"prefix":"10.14336","member":"5462","published-online":{"date-parts":[[2026]]},"container-title":["aging and disease"],"original-title":[],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:52:49Z","timestamp":1780671169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2026.0292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"URL":"https:\/\/doi.org\/10.14336\/ad.2026.0292","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}